Pathophysiology of Congestive Heart Failure Explained

Introduction to Pathophysiology and CHF

The pathophysiology of congestive heart failure is incredibly complex, making it difficult for modern healthcare practitioners to fully define its conditions and driving the need to further explore the disease process. With so many people around the world suffering from the life-altering effects of congestive heart failure, it is important that contemporary medical practice remains active in defining the pathophysiology of the condition. A clearer understanding will ultimately help improve recognition of symptoms and allow patients to receive the help they need more quickly.

Concepts within pathophysiology emerge from combining pathology with elements of physiology. Together, these disciplines blend in synergy to provide a more vivid picture of the effects of congestive heart failure, among other serious conditions and diseases. Pathophysiology is fundamentally concerned with observing and working toward solutions for the changes that result from a condition or disease. The pathophysiology of congestive heart failure is therefore simultaneously active in defining symptoms as they occur and in examining how other systems in the body are impacted by the presence of a serious cardiac condition.

Congestive Heart Failure: Mechanisms and Symptoms

In today's health environment, cardiac issues are among the most serious faced by medical practitioners. A number of conditions fall under this broader conceptual term. Essentially, "heart failure is a clinical syndrome characterized by systemic perfusion inadequate to meet the body's metabolic demands as a result of impaired cardiac pump function" (Hobbs & Boyle, 2010). The more specific condition analyzed in this pathophysiological evaluation is congestive heart failure — a type of heart failure involving the swelling and congestion of blood in the heart due to an inability to properly pump blood to where it is needed throughout the body.

Interestingly, "most patients with HF do not complain of symptoms at rest, but rather with physical exertion" (Borlaug & Paulus, 2011, p. 674). This often makes it difficult to diagnose an early onset of the condition without the patient noticing potential pain or other symptoms during their daily activities. The stress of exercise frequently activates abnormalities in the reserve functions of the heart (Borlaug & Paulus, 2011), significantly impairing normal and systolic reserves. Still, congestive heart failure is a serious condition that causes massive degeneration of other organs due to a lack of proper blood flow. Research suggests that it begins "as a single organ disease" but "becomes a systemic disease during its evolution and progression" (Galli et al., 2010, p. 155). Without the heart functioning at full capacity, the other systems of the body are soon placed at risk.

There are a number of pathophysiological signs observable in cases of congestive heart failure. Most patients present with signs and symptoms of "fluid overload and pulmonary congestion, including dyspnea, orthopnea, and paroxysmal nocturnal dyspnea" (Hobbs & Boyle, 2010). These are among the more obvious indicators that cardiac issues may be endangering the patient's health and well-being. More immediate symptoms can include "renal dysfunction, cachexia, valvular regurgitation, ventricular arrhythmias, higher NYHA heart failure class, lower LV ejection fraction (LVEF), high catecholamine and B-type natriuretic peptide (BNP) levels, low serum sodium level, hypocholesterolemia, and marked LV dilation" (Hobbs & Boyle, 2010). One of the major signs is an excess volume of blood in the heart that is not being pushed out to the rest of the body, which is deprived of oxygen. This is the primary cause of pulmonary and/or venous congestion.

Congestive heart failure is a direct result of "depressed left-sided cardiac function" (Aucoin, 2011, p. 12). The left side of the heart becomes overworked as it attempts to pump out blood that is backing up and causing congestion, leading to abnormal functioning of the entire cardiac system. Dilation of the left ventricular (LV) chamber "can cause mitral annular dilation and mitral regurgitation, leading to pulmonary congestion" (Hobbs & Boyle, 2010). As the left ventricular chamber continues to dilate, the rate of congestion within the heart increases, and the dangers associated with congestive heart failure intensify.

The left ventricle is the most affected chamber because it is responsible for pumping blood to the rest of the body. Blood continues to enter the heart but struggles to be expelled, producing "diastolic LV dysfunction, which consists of prolonged isovolumic LV relaxation, slow LV filling, and increased diastolic LV stiffness" (Borlaug & Paulus, 2011, p. 671). This process causes increased pressure in both ventricles, with greater impact on the left chamber, which serves as a lifeline for the body's other organs. During such states of congestive heart failure, "the heart's ability to pump out a normal stroke volume" is severely impaired, causing major damage to the cardiac and other organ systems (Aucoin, 2011, p. 15). The resulting decrease in cardiac output leads many patients to suffer and die from "end-organ failure resulting from inadequate systemic organ perfusion, particularly to the kidneys" (Hobbs & Boyle, 2010).

Research by Li et al. (2012) examined a more specific instance of congestive heart failure in order to define its pathophysiology. Their work explored dilated cardiomyopathy (DCM), "a cardiac muscle disorder characterized by systolic dysfunction and ventricular chamber dilation" and "a major cause of congestive heart failure" (Li et al., 2012, p. 1). This abnormality in the cardiac muscle results from established risk factors, but emerging research also suggests it can arise from hereditary causes, with findings indicating a genetic link to DCM. Li et al. (2012) conclude with evidence showing clear signs of congestive HF, including "severe pulmonary edema and dyspnea associated with marked changes in myocardial expression of biomarkers of HF" (p. 5). Thus, certain elements of the pathophysiology of congestive heart failure extend beyond lifestyle factors and are determined by genetic biomarkers.

It is clear that the cardiac system is intimately connected to all other organ systems in the body. Congestive heart failure therefore impacts not only the heart and cardiovascular system, but other bodily systems as well. One major area affected by abnormal cardiac functioning is cognitive functioning. Research illustrates that "depression is associated with poor prognosis in patients with HF, with higher prevalence rates of depression being associated with higher NYHA functional class" (Li et al., 2012, p. 1). Li et al. (2012) associate this with a malfunction in serotonin release linked to the pathophysiology of congestive heart failure. Consequently, the severity of a patient's depression may correlate with the severity of the condition itself, given the neurological connection between the brain's serotonergic activity and abnormal cognitive functioning resulting from congestive heart failure.

Impact on the Brain and Nervous System

The entire nervous system is also significantly affected by such a damaging cardiac condition. Li et al. (2012) note that "the autonomic areas of the lower brainstem and spinal cord that involve regulation of the cardiovascular system" can display clear symptoms when a patient is in a state of congestive heart failure (p. 6). The researchers further suggest that "brain 5-HT dysfunction, due at least in part to the loss-of-function SNP C1473G in the TPH2 gene, might play a promotive role in the development of congestive HF" (Li et al., 2012, p. 6).

The pathophysiology of congestive heart failure also impacts the sympathetic nervous system. Sympathetic activation can cause tachycardia and increased myocardial oxygen consumption. Research shows that the sympathetic nervous system "increases heart rate and contractility, causes arteriolar vasoconstriction in nonessential vascular beds, and stimulates secretion of renin from the juxtaglomerular apparatus of the kidney" (Hobbs & Boyle, 2010). When abnormal cardiovascular conditions arise due to congestive heart failure, sympathetic nervous system function is severely disrupted. Activation leads to "peripheral vasoconstriction to preserve blood pressure homeostasis in vital areas and regulate sodium and water retention to preserve blood volume" (Galli et al., 2010, p. 155).

Peripheral vasoconstriction is often directly related to the condition's impact on the sympathetic nervous system. The body begins to retain salt and water when the renin-angiotensin system is activated, and fluid retention becomes one of the more observable signs of the disease. Fluid retention is also caused by vasoconstrictor neurohormones. Research suggests that "cardiac depression may also cause fluid to back up into the pulmonary system, resulting in pulmonary edema" (Aucoin, 2011, p. 12). Additionally, increasing releases of aldosterone can cause the body to retain fluid and sodium, potentially leading to endothelial dysfunction and organ fibrosis (Hobbs & Boyle, 2010).

Conclusion: Future Recommendations for Clinical Practice

Galli, E., Pingitore, A., & Iervasi, G. (2010). The role of thyroid hormone in the pathophysiology of heart failure: Clinical evidence. Heart Failure Reviews, 15(2), 155–169.

Hobbs, R., & Boyle, A. (2010). Heart failure. Disease Management Project. Cleveland Clinic.

Li, L., Morimoto, S., Take, S., Zhan, D. Y., Du, C. K., Wang, Y. Y., & Sasaguri, T. (2012). Role of brain serotonin dysfunction in the pathophysiology of congestive heart failure. Journal of Molecular and Cellular Cardiology.